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Abstract 
Current evidence indicates that the use of Complementary Health Approaches (CHA) is common 
among people with cardiovascular disease (CVD) and can come with both benefits and risks. Yet 
disclosure of CHA use to physicians is not uniformly high. The aim of the current study was to 
assess the prevalence and patterns of CHA use and disclosure among people with CVD in a 
nationally representative US sample, using the 2012 NHIS data. Use of specific CHA modalities, 
and the predictors and reasons for non-disclosure were examined. The 2012 National Health 
Interview Survey, a nationally representative sample of adults 18+ was used and 12,364 
individuals who reported being diagnosed with CVD were analysed using weighted bivariate and 
logistic regression. Analyses revealed that 34.75% of those with CVD had used CHA in the 
previous year. Women, those with higher education and income, who had functional limitations, 
greater mental distress, and healthier lifestyles were significantly more likely to use CHA. Non-
vitamin, non-mineral (NVNM) supplements was the most prevalent CHA used (19.22%). Rates 
of non-disclosure were highest among younger and better educated CHA users. Among those 
with CVD who did not disclose CHA use to their physician (33.67%), 45.51% said the reason 
was because physician did not ask; only 8.75% said the reason was because they were not using 
CHA at the time. In conclusion, over a third of people with CVD used CHA in the previous year, 
and NVNM were the most commonly used modality. Findings underscore the importance of 
provider-initiated communication about CHA use in CVD patients to minimize the potentially 
harmful consequences of non-disclosure. 
 
KEY WORDS: Complementary health approaches; non-disclosure; cardiovascular disease 
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Complementary Health Approaches (CHA) consist of a diverse set of healing approaches 
of differing practices, health systems, and products that are not generally considered part of 
conventional medicine. CHA is an increasingly popular health-care option among cardiac 
patients 1, with the prevalence of CHA use reported to be as high as 61 percent when used in 
general, and 82 percent when used specifically to treat cardiovascular disease (CVD) 2. Yet 
disclosure of CHA use to physicians is not uniformly high 2. Non-disclosure of CHA poses some 
potential risks because non-vitamin, non-mineral and herbal products, one of the most commonly 
used groups of CHA among cardiac patients 3,4, can interact with medications or have adverse 
effects on the cardiovascular or haemostatic system 5. For example, herbal products such St. 
John’s Wort decrease serum digoxin concentration, whereas Hawthorn increases the effects of 
digoxin 4. Products such as Ma-huang (a.k.a. ephedra) can increase heart rate and blood pressure 
5
, and result in adverse cardiovascular effects such as stroke and myocardial infarction 1. Full 
disclosure of CHA use, whether for CVD or other health issues, is crucial to minimise patient 
harm.  The purpose of the current study was to assess the prevalence and patterns of CHA use 
and disclosure among people with CVD in a nationally representative US sample, as well as the 
reasons for non-disclosure, using the 2012 National Health Interview Survey (NHIS) data 
containing the most recent CHA information.  
METHODS 
 The NHIS 2012, the most recent NHIS survey, was the source of the data used for these 
analyses. The NHIS is an ongoing, cross-sectional household interview survey of the US civilian, 
non-institutionalized population and uses a multistage area probability design 6. Every five years 
an Adult Alternative Medicine supplement is administered to a randomly selected adult age 18 or 
over in the household (Sample Adult Core) (n = 34,525). In 2012, the Sample Adult Core 
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response rate was 79.7% 6. For this analysis, the sample included all adults who completed the 
Alternative Medicine Supplement and stated they were diagnosed with a heart condition. 
Following earlier research that used the 2002 NHIS to investigate CVD and CHA users (11), we 
created a composite measure of CVD that included individuals in the NHIS who said they had 
ever been diagnosed by a physician for having: 1) hypertension; 2) coronary heart disease; 3) 
angina; 4) heart attack; or 5) any other kind of heart disease. Based on these criteria, the final 
analytic sample size was 12,364. The study was exempt from human subjects and from the 
university’s institutional review board because the data are de-identified and publicly available.  
Measures 
 The primary outcome was use of any type of CHA in the past 12 months. Adults were 
first asked if they had ever used any of over 20 types of specific CHA modalities (e.g., 
acupuncture, massage, yoga, meditation, natural products, and so on), and if they responded 
affirmatively, were then asked if it was used in the past 12 months. Any mention of CHA was 
coded as a “yes.” The final variable was coded as a dichotomy. In addition, we also reported on 
use of the top 10 types of specific CHA modalities. Among individuals with CVD who were 
recent CHA users, we also examined prevalence of non-disclosure of CHA use to their 
conventional health care provider (almost entirely physicians, over 96%) and the reasons 
mentioned for not disclosing.  
 Gender was coded as a dichotomy. Age was coded ordinally (18-29, 30-49, 50-64, 65+), 
as was education (< high school, some college, baccalaureate or higher), and income (< $34,999, 
$35,000-49,999, $50,000-74,999, $75,000-99,000, and >$100,000). Race and ethnicity were 
based on self-report with any mention of being Hispanic/Latino given priority (Hispanic, Non-
Hispanic White, Non-Hispanic Black, Non-Hispanic Asian, Other). Marital status was coded 
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categorically (married, cohabitating, divorced/separated/widowed, never married). Current health 
status was operationalized as having any functional limitation (yes, no), mental distress as 
measured by the Kessler K6 scale 7 (yes, no), and a healthy behavior index that was a composite 
score of the total number of healthy behaviors out of four (not smoking, little or moderate 
alcohol consumption, normal BMI, and adequate physical activity).  
 Univariate descriptive statistics and bivariate associations between each covariate and 
any type of CHA use were computed. Design-based F tests were employed for bivariate analysis. 
Logistic regression was used for multivariate analyses and adjusted odds ratios (AORs) and 95% 
confidence intervals (CI) are presented. All analyses were weighted using the individual 
sampling weights to account for complex sample design. Analyses were conducted with Stata 
statistical software version 13.1 8. 
RESULTS 
 Over three-quarters of adults with CVD were 50 and older; about three-quarters were 
White, followed by Black, Hispanic/Latino, Asian, and other races (see Table 1). The vast 
majority were born in the US. They tended to be of lower socioeconomic status (SES) with the 
majority completing high school or less and in the lowest income category. Most were either 
currently married or divorced, separated, or widowed. Over half reported at least some functional 
limitation but less than 5 percent scored higher on the K6 scale. Over one-third reported less than 
two healthy behaviors. They were less likely to be Hispanic/Latino, foreign born, be college 
graduates, or have higher incomes, or to be cohabiting, divorced/widowed. Last, they were more 
likely to be never married, have functional limitations, higher K6 score, and less likely to engage 
in a greater number of healthy behaviors (See Supplemental Table 1.) 
Overall, just over a third of individuals with CVD used CHA in the past year (Table 1). 
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At the bivariate level, there were significant differences between those who used CHA versus 
those who did not except for functional limitations and mental distress. CHA use was higher 
among females, younger adults, Asians, Whites, and other races, among those who were US 
born, and had higher SES. CHA was highest among cohabiting and married adults and 
incrementally increased as the number of healthy behaviors increased. In additional multivariate 
analysis that included the full NHIS sample, individuals with CVD had significantly higher odds 
of CHA use compared to those without heart problems (AOR = 1.14, 95% CI: 1.06, 1.23), net of 
demographics, health conditions, and health behaviors (see Supplemental Table 2).  
Women had higher odds of use than men, and those who were 65+ had lower odds than 
the youngest age group (Table 1). Compared to Whites, Hispanics and Blacks had lower odds of 
use. Both higher levels of education and higher incomes were associated with greater odds of 
use. Compared to married persons, those who were divorced had higher odds. Those with 
functional limitations or greater mental distress had higher odds of use as did individuals who 
engaged in greater numbers of health behaviors.  
With respect to the specific types of CHA modalities used by adults with CVD, over half 
took multivitamins/mineral tablets (Table 2). Almost 1 in 5 used non-vitamin, non-mineral 
(NVNM) and herbal products, followed by chiropractic/osteopathic manipulation, massage, 
mind-body techniques, and relaxation techniques. The remaining modalities were less commonly 
used. Except for NVNM and chiropractic, there were significant gender differences in use.  
Additional logistic regression analyses for each of the top 5 modalities (e.g., multivitamin, 
natural products, chiropractic, massage, and mind-body) revealed that, regardless of modality, 
users were more likely to be white, have higher levels of education and income, have functional 
limitations, and greater numbers of health behaviors (results available from authors). 
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About one-third did not disclose their use of CHA to their physician (Table 3). Among 
those who did not disclose, the most common reason stated was that the provider did not ask. 
Slightly over 1 in 5 provided no reason for non-disclosure, followed by users’ beliefs that their 
provider did not need to know. Less than ten percent did not disclose because they were not 
using CHA at the time they saw their provider, and very few noted perceptions of negative 
reactions from their physicians as a reason for non-disclosure.  
 The logistic regression of CHA users who did not disclose to their physicians found that 
compared to the youngest adults with CVD, those who were the oldest had significantly lower 
odds of non-disclosure of their CHA use, as did those who were foreign-born, and those who had 
functional limitations (Table 4). In contrast, those with the highest level of education or who 
were cohabiting or never married (versus married) had higher odds of non-disclosure. 
DISCUSSION 
In this analysis of the 2012 NHIS data, a nationally representative sample of Americans, 
over a third of people with CVD reported using CHA in the previous year. Rates of use were 
higher among those in the highest income categories, and those with a bachelor’s degree using 
CHA. The demographic predictors of CHA use were consistent with research with the general 
population 9,10, with women, and adults who were younger, White, and who had higher SES, 
functional limitations, and mental distress more likely to use CHA. Non-vitamin, non-mineral 
natural products were used by about a fifth of those with CVD, and rates of non-disclosure of 
CHA use to physicians was reported by about a third of adults, with rates highest among younger 
age groups and those with higher education levels. Importantly, not being asked by their 
physician was the most commonly reported reason for non-disclosure.  
 The current findings parallel previous results from the 2002 NHIS with respect to rates of 
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CHA use and the popularity of non-vitamin, non-mineral supplements and herbal products 
among people with CVD 11, and thus their potential risk. In the US herbal medications do not 
require approval or testing for their safety or effectiveness for certain conditions as they fall 
under a category of dietary supplements within the FDA 12. Both herbal products and non-
vitamin, non-mineral supplements are perceived as being natural and therefore safe 13, 
contributing further to potential misuse among CVD patients. 
In the current analysis, the rate of disclosure of CHA use to health-care providers among 
those with CVD was greater than the disclosure rate noted in the 2002 NHIS 11, and was similar 
to the rate found among the general population 14. Although the lower rate of non-disclosure in 
2012 compared to 2002 is promising, when considered in light of the high rates of CHA use in 
certain groups and the reasons for non-disclosure, the current findings highlight the importance 
of physicians asking their CVD patients about CHA use. The most reported reason for not 
disclosing CHA use was because the provider did not ask, which is consistent with the main 
reason for non-disclosure in the general population 14. Ostensibly, this reflects issues in 
physician-initiated communications regarding CHA use, and underscores the need for physicians 
to ask about the details of CHA modalities used by their patients.  
Aside from high use of herbal and supplement use, CVD patients also used other CHA 
modalities such as massage, mind-body practices, and relaxation techniques. These CHA are 
known to be  useful for reducing stress 15,16, which in turn can have beneficial downstream 
effects with respect to cardiac health 17,18. Nonetheless, the timing of initiating discussion about 
CHA is an important consideration. Evidence indicates that people may begin CHA use after 
experiencing myocardial infarction (MI). In one study of CVD patients from 24 US sites, a third 
reported initiating use of CHA within the year after experiencing MI, with mind-body therapies, 
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and biological therapies as the most commonly adopted CHA modalities 19. Given this, initiating 
discussion about CHA use upon intake, and following up regarding any changes in CHA use 
over time may be the best strategy to minimise potential issues associated with non-disclosure, 
such as harmful interactions 4 or reduced adherence to CVD medication 20.  
The findings from the current study should be considered in light of several limitations and 
strengths. Participants were only asked about whether or not they disclosed CHA, and not about 
the type of CHA that was disclosed, or whether CHA was being used for CVD or other medical 
issues. Therefore, it is unknown whether the rates of disclosure were higher or lower for more 
concerning CHA modalities, such as herbal and natural supplements, or for other forms of CHA 
which may be beneficial for managing stress. It is also unclear if disclosure was patient initiated 
or provider initiated, although not being asked by the provider about CHA use as a main reason 
for non-disclosure indicates that providers may have initiated these conversations. Further work 
is needed to improve understanding of how disclosure may vary across CHA modalities and 
communication scenarios. Despite these limitations, the use of a large nationally representative 
sample of people with CVD who use CHA is a clear strength of the study that supports the 
robustness and generalizability of the findings.  
In conclusion, in a large nationally representative US sample we found that over a third 
of people with CVD used CHA in the previous year, and that non-vitamin, non-mineral 
supplements and herbal products were one of the most commonly used CHA modalities. Rates of 
non-disclosure, though lower than those found in the 2002 NHIS, remaining concerning, and 
were highest among younger and better educated CHA users. The main reason for non-disclosure 
was not being asked by the health-care provider, underscoring the importance of provider-
initiated communication about CHA use in CVD patients. 
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Table 1. Demographic, health, and health behavior characteristics, prevalence of 
Complementary Health Approaches (CHA) use, and logistic regression results of CHA use, 
adults with cardiovascular diseases, National Health Interview Survey, 2012 (N = 12,364) 
  CHA use  AOR 95% CI 
Total 100.00%   34.75% -- -- 
Sex     
    Male 45.76% 32.26%*** 1.00 -- 
    Female 54.24% 36.85% 1.42 (1.29, 1.56) 
Age (years)     
    18-29 years old 5.20% 40.25%*** 1.00 -- 
    30-49 years old 19.50%  38.41% 0.92 (0.71, 1.18) 
    50-64 years old 33.61%  37.69% 0.85 (0.66, 1.09) 
    65+ years old 41.69%  29.91% 0.55 (0.45, 0.76) 
Race/ethnicity     
    NH-White 72.59%  37.90%*** 1.00 -- 
    Hispanic 8.84%  26.33% 0.71 (0.60, 0.84) 
    NH-Black 14.66%  23.11% 0.53 (0.47, 0.60) 
    NH-Asian 3.05%  39.31% 1.02 (0.79, 1.12) 
    NH-Other 0.86%  37.68% 1.06 (0.66, 1.71) 
Nativity      
    Born in US 88.52% 35.35%*** 1.00 -- 
    Foreign born 11.48%  30.17% 0.94 (0.79, 1.12) 
Education attainment      
    High school and less 45.41% 24.46%*** 1.00 -- 
    Some college 30.98%  39.26% 1.71 (1.53, 1.92) 
    College and above 23.60%  48.63% 2.27 (2.01, 2.57) 
Annual family income     
    $ 0-34,999 46.19% 27.48%*** 1.00 -- 
    $ 35,000-49,999 14.64%  35.43% 1.29 (1.12, 1.480 
    $ 50,000-74,999 16.11%  39.14% 1.35 (1.17, 1.57) 
    $ 75,000-99,000 9.11%  45.61% 1.68 (1.39, 2.02) 
    $ 100,000+ 13.96%  45.97% 1.46 (1.229, 1.731) 
Marital status     
    Married 43.93% 36.54%*** 1.00 -- 
    Cohabiting  3.76%  39.99% 1.10 (0.94, 1.28) 
    Divorced/separated/ 
     widowed 
38.16%  31.72% 1.28 (1.02, 1.61) 
    Never married 14.15%  36.00% 1.05 (0.94, 1.17) 
Functional limitation     
    Limited  59.43%  35.48% 1.00 -- 
    Not limited  40.57%  33.69% 1.49 (1.34, 1.65) 
K6 scores     
    0-12 95.15%  34.64% 1.00 -- 
    13-24 4.85%  36.91% 1.28 (1.04, 1.57) 
Healthy behavior index 
(continuous) 
  1.38 (1.29, 1.46) 
Healthy behavior index      
    0 4.71% 23.23%*** -- -- 
    1 36.04%   28.01% -- -- 
    2 43.18%   36.44% -- -- 
    3 14.20%   47.98% -- -- 
    4 1.87%   60.91% -- -- 
Notes: NH=Non-Hispanic. AOR = Adjusted odds ratio; CI = confidence interval; Weighted 
percentages and AOR. Bivariate results based on design-based F test. ***p<.001. See text for 
further detail.  
 
 
Table 2. Rank order and prevalence of use of specific Complementary Health Approaches 
(CHA) modalities among recent users with cardiovascular diseases, National Health 
Interview Survey,  2012 (N = 12,364) 
Rank Type of CHA Prevalence 
 
 Total Male Female p-value 
1 Multi-vitamin or multi-mineral supplement 55.78% 52.29% 58.72% <0.0001 
2 Non-vitamin, non-mineral or herbal 
supplement 
19.92% 19.59% 20.20% 0.4958 
3 Chiropractic or osteopathic manipulation 9.20% 8.88% 9.48% 0.3096 
4 Massage 8.19% 6.52% 9.59% <0.0001 
5 Mind-body techniques: Yoga, Tai Chi or Qi 
Gong 
6.49% 4.10% 8.50% <0.0001 
6 Relaxation techniques: Meditation, guided 
imagery or progressive relaxation 
4.86% 4.15% 5.47% 0.0064 
7 Special diet 3.09% 2.66% 3.45% 0.0294 
8 Homeopathy  1.95% 1.41%% 2.40% 0.0017 
9 Acupuncture  1.63% 0.31% 1.75% <0.0001 
10 Movement techniques: Feldenkrais, Pilates, 
Trager psychophysical integration, or 
Alexander technique 
1.09% 1.09% 2.09% 0.0001 
Notes: Weighted percentages. Bivariate analysis for design-based F-test. See text for further 
detail. 
 
 
 
 
Table 3. Reasons for non-disclosure of Complementary Health Approaches (CHA) use to 
physician, adults with cardiovascular diseases, National Health Interview Survey,  2012 (N = 
3,068) 
 Reasons for not disclosing CHA use                         
1 They didn’t ask  45.51% 
2 No reason provided 23.89% 
3 Didn’t think they needed to know  9.44% 
4 Weren’t using therapy at the time  8.75% 
5 Didn’t think they knew as much about therapy as you do  6.19% 
6 They didn’t give you enough time to tell them  5.52% 
7 Concerned about a negative reaction  0.39% 
8 They discouraged use of therapy in the past  0.20% 
9 Worried they would discourage it  0.12% 
Notes: Weighted percentages. See text for further detail. 
 
 
 
Table 4. Logistic regression results of non-disclosure of Complementary Health Approaches 
(CHA) use to physician, adults with cardiovascular diseases, National Health Interview 
Survey, 2012 (N = 3,068) 
 Non-Disclosure of CHA 
 AOR 95% CI 
Sex   
    Male 1.00  
    Female 1.14 (0.93, 1.39)  
Age (years)   
    18-29 years old 1.00  
    30-49 years old 0.72 (0.43, 1.22) 
    50-64 years old 0.64 (0.38, 1.06) 
    65+ years old 0.49 (0.29, 0.84) 
Race/ethnicity   
    NH-White 1.00  
    Hispanic 1.29 (0.91,  1.81) 
    NH-Black 0.95 (0.71, 1.27) 
    NH-Asian 1.14 (0.70, 1.86) 
    NH-Other 1.59 (0.63, 4.02) 
Nativity    
    Born in US 1.00  
    Foreign born 0.67 (0.46, 0.97) 
Education attainment    
    High school and less 1.00  
    Some college 1.17 (0.92, 1.48) 
    College and above 1.28 (1.21, 1.69) 
Annual family income   
    $ 0-34,999 1.00  
    $ 35,000-49,999 0.84 (0.63, 1.12) 
    $ 50,000-74,999 1.17 (0.87, 1.58) 
    $ 75,000-99,000 1.03 (0.74, 1.43) 
    $ 100,000+ 1.06 (0.79, 1.41) 
Marital status   
    Married 1.00  
    Cohabiting  1.47 (1.05, 2.06) 
    Divorced/separated/widowed 1.43 (0.89, 2.29) 
    Never married 1.26 (1.01, 1.56) 
Functional limitation   
   Not limited 1.00  
   Limited  0.71 (0.58, 0.86) 
K6 scores   
    0-12 1.00  
    13-24 1.05 (0.66, 1.66) 
Healthy behavior index  1.07 (0.95, 1.20) 
Notes: AOR = Adjusted odds ratio; CI = confidence interval; Weighted analysis. See text for 
further detail. 
Supplemental Table 1. Logistic regression results of characteristics of individuals with 
cardiovascular diseases versus none, National Health Interview Survey, 2012 (N=33,594) 
 AOR 95% CI 
Sex   
    Male 1.00  
    Female 0.74 (0.69, 0.79) 
Age (years)   
    18-29 years old 1.00  
    30-49 years old 2.21 (1.97, 2.49) 
    50-64 years old 6.05 (5.36, 6.82)  
    65+ years old 13.27 (11.58, 15.21) 
Race/ethnicity   
    NH-White 1.00  
    Hispanic 0.85 (0.77, 0.95) 
    NH-Black 1.58 (1.45, 1.72) 
    NH-Asian 1.06 (0.92, 1.22) 
    NH-Other 1.31 (0.94, 1.83) 
Nativity    
    Born in US 1.00  
    Foreign born 0.77 (0.71, 0.85) 
Education attainment    
    High school and less 1.00  
    Some college 1.04 (0.96, 1.12) 
    College and above 0.85 (0.78, 0.94) 
Annual family income   
    $ 0-34,999 1.00  
    $ 35,000-49,999 0.89 (0.82, 0.98) 
    $ 50,000-74,999 0.92 (0.83, 1.01) 
    $ 75,000-99,000 0.90 (0.80, 1.01) 
    $ 100,000+ 0.87 (0.78, 0.98) 
Marital status   
    Married 1.00  
    Cohabiting  0.90 (0.82, 0.99) 
    Divorced/separated/widowed 0.85 (0.74, 0.97) 
    Never married 1.09 (1.02, 1.17) 
Functional limitation   
   Not limited 1.00  
   Limited  2.39 (2.25, 2.54) 
K6 scores   
    0-12 1.00  
    13-24 1.68 (1.410 2.00) 
Healthy behavior index  0.74 (0.72, 0.76) 
Notes: AOR = Adjusted odds ratio; CI = confidence interval; Weighted analysis. See text for 
further detail. 
  
Supplemental Table 2.  Results of logistic regression of recent Complementary Health Approaches 
(CHA) use on cardiovascular disease (CVD) status controlling for socio-demographic characteristics 
and health conditions among American adults, National Health Interview Survey, 2012 (N=33,594, 
weighted) 
 CHA use 
 AOR 95% CI 
CVD status   
    Without CVD 1.000  
    With CVD  1.139 (1.058, 1.226) 
Covariates   
Sex   
    Male 1.000  
    Female 1.499 (1.414, 1.588) 
Age (years)   
    18-29 years old 1.000  
    30-49 years old 1.177 (1.079, 1.284) 
    50-64 years old 1.101 (0.989, 1.226) 
    65+ years old 0.737 (0.652, 0.834) 
Race/ethnicity   
    NH-White 1.000  
    Hispanic 0.704 (0.637, 0.779) 
    NH-Black 0.487 (0.443, 0.534) 
    NH-Asian 1.046 (0.915, 1.195) 
    NH-Other 1.103 (0.822, 1.480) 
Nativity    
    Born in US 1.000  
    Foreign born 0.808 (0.733, 0.891) 
Education attainment    
    High school and less 1.000  
    Some college 1.797 (1.680, 1.923) 
    College and above 2.370 (2.197, 2.556) 
Annual family income   
    $ 0-34,999 1.000  
    $ 35,000-49,999 1.208 (1.113, 1.311) 
    $ 50,000-74,999 1.302 (1.183, 1.432) 
    $ 75,000-99,000 1.385 (1.241, 1.546) 
    $ 100,000+ 1.438 (1.302, 1.589) 
Marital status   
    Married 1.000  
    Cohabiting  1.157 (1.069, 1.252) 
    Divorced/separated/widowed 1.181 (1.050, 1.328) 
    Never married 1.085 (1.006, 1.169) 
Functional limitation   
   Not limited 1.000  
   Limited  1.692 (1.580, 1.812) 
K6 scores   
    0-12 1.000  
    13-24 1.227 (1.049, 1.436) 
Healthy behavior index  1.388 (1.343, 1.435) 
Notes: AOR = Adjusted odds ratio; CI = confidence interval. 
